KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Total Current Liabilities (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Total Current Liabilities for 9 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 21.44% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 21.44% year-over-year, with the annual reading at $1.6 billion for FY2025, 21.44% up from the prior year.
  • Total Current Liabilities hit $1.6 billion in Q4 2025 for Elanco Animal Health, up from $1.5 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $2.0 billion in Q1 2021 to a low of $1.2 billion in Q1 2024.
  • Historically, Total Current Liabilities has averaged $1.5 billion across 5 years, with a median of $1.4 billion in 2021.
  • Biggest five-year swings in Total Current Liabilities: surged 187.49% in 2021 and later plummeted 35.74% in 2022.
  • Year by year, Total Current Liabilities stood at $1.6 billion in 2021, then grew by 3.34% to $1.7 billion in 2022, then fell by 27.09% to $1.2 billion in 2023, then rose by 5.96% to $1.3 billion in 2024, then rose by 21.44% to $1.6 billion in 2025.
  • Business Quant data shows Total Current Liabilities for ELAN at $1.6 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.4 billion in Q2 2025.